السلام عليكم
النزول شي طبيعي لسهم ارتفع بدون اخبار
=========================
والهبوط تجميع وارباح معا عند وصول السهم 4,95 قاموا مضاربين بشكل
كبير بعرض السهم 3.60 علما بان الطلب كان 4,95 وكذلك مجموعه كبيره
تطلب السهم 4,90 علما بان السهم وصل 3.15 تقريبا
اكثر اسباب الهبوط المفاجي هو هذا العرض قيام اكثر من 5000 شخص
او اكثر بعرض السهم بالنزول وبعدد لا يتجاوز الواحد منهم 100 سهم فقط
علما بان المطلوب اكثر من المعروض وعلى ما افتكر كان المطلوب بحدود 140 الف سهم والمعروض لايتعدي 36000 الف سهم
توقعي لشركة قوي جدا اللى صار تصير وارباح وتجميع بنفس الوقت
وانشاء الله قريبا مع الاخبار الممتازة وانتشار المرض في الولايات الامريكية
بس ننتظر اعلان 5 ولايات وجود الوباء سوف يقلع السهم بشكل كبير
لا ابالغ ولكن متوقع له 7 حتي 9 دولارات ويستقر سعر السهم باذن الله
----------------
للعلم بعد اغلاق السوق هناك خبر نزل بموقع الشركة فقط وهو المكتوب بالاسفل
علما بان امريكا راصدة 3,7 مليار للقاح فقط
================
Antigen working with FDA to fast-track flu vaccine
March 24, 2006
Antigen working with FDA to fast-track flu vaccine
BOSTON BUSINESS JOURNAL
BY KEITH REGAN
SPECIAL TO THE JOURNAL
WORCESTER - Antigen Express Inc. hopes to begin early-stage clinical trials as early as this fall on a synthetic peptide vaccine that could be made simply, quickly and in large quantities to help prepare for a possible avian flu pandemic.
The Worcester firm met last month with the U.S. Food and Drug Administration and said the federal agency gave it clear instructions for moving ahead in the approval process for its vaccine - a road map that could have Antigen Express filing an Investigational New Drug application with the FDA within a matter of weeks.
"The FDA was uncharacteristically outgoing," said Eric yon Hafe, president of the eight-person firm, a wholly owned subsidiary of Toronto-based Generex Biotechnology Corp. (Nasdaq: GNBT). "They made it clear what they wanted to see from us."
The United States has seen flu vaccine shortages in recent years, and there is widespread concern that should an avian flu pandemic hit it could take years to produce enough vaccine through traditional means, which involve growing the drugs in eggs or cell cultures.
"We could produce it on a 100-kilogram scale at anyone of a number of contract manufacturers we work with. It's conceivable we could produce enough to vaccinate the majority ofthe U.S. population," said von Hofe.
Concern about an avian flu pandemic continues to mount. Last year, Congress set aside $3.8 billion to aid in preparedness, and several agencies have taken steps to speed production of new treatments, tests and vaccines. According to the Centers for Disease Control, human cases of the avian flu have now been confirmed in 37 countries, with 175 people infected and 96 dead.
At least one other firm, San Diego based Vicallnc. (Nasdaq: VI CL), is working to develop an alternative avian flu vaccine-production method using bacteria to produce its DNA vaccine.
In early March, the FDA issued guidelines clarifying the data it wants from vaccine makers. Acting FDA Commissioner Dr. Andrew von Eschenbach said that move "illustrates FDAs high level of commitment and key role in preparing for influenza pandemic, which is a top priority for our nation."
The FDA created an accelerated approval pathway for the vaccine Fluarix, used to prevent type A and B influenza, in 2005. A new lab test that reduces the time it takes to confirm avian flu from days to hours was also approved on an expedited schedule, with the FDA using what von Eschenbach called "flexible regulatory authorities."
Von Hofe hopes his firm's applicalions will benefit from that flexibility and from regulators' desire to have more vaccines in the pipeline. Antigen Express intends to finish pre-clinical toxicity tests by late summer and is designing Phase I trials.
Antigen Express was founded in 1994 based on work von Hofe and Dr. Robert Humphries did at University of Massachusetts Medical School. Generex purchased the firm in 2003.
=====
الخبر من موقع الشركة فقط ولم بنزل اي خبر لا في الياهو ولا في النازدك
من تاريخ اخر خبر لشركة وهو 16 - 3
والله ولي التوفيق
علما بانني محتفظ بالاسهم من سعر 1,14 فقط لاغير
ولن يسكر خسارتي الا 7.20 خسائر 3 سنوات كفاح مع الاسهم والله كريم
